Calcium drives every heartbeat. The opening and closing of calcium channels determine how strongly the heart contracts, how well it relaxes, and how stable its rhythm remains. At the same time, the PI3K signaling pathway quietly governs many of these calcium-dependent processes by controlling channel density, receptor sensitivity, and cellular micro-domains.

This review explores how different PI3K isoforms—especially PI3Kα and PI3Kγ—shape calcium handling in cardiomyocytes, smooth muscle, endothelial cells, and immune cells. Their effects range from maintaining normal contractility to contributing to diabetic cardiomyopathy, hypertension, heart failure, and vascular inflammation.

Understanding this crosstalk is increasingly important. As PI3K-targeted drugs enter clinical practice in oncology and immunology, their influence on cardiac calcium regulation has become a critical consideration for both safety and therapeutic innovation.

The attached PDF provides a comprehensive scientific overview of these mechanisms and highlights why PI3K-calcium signaling is emerging as a key axis in cardiovascular disease development and treatment strategy.